Genetic analysis of synchronous mucinous tumors of the ovary and appendix

被引:70
作者
Chuaqui, RF
Zhuang, ZP
Emmertbuck, MR
Bryant, BR
Nogales, F
Tavassoli, FA
Merino, MJ
机构
[1] NCI, PATHOL LAB, BETHESDA, MD 20892 USA
[2] UNIV GRANADA, GRANADA, SPAIN
[3] FAIRFAX HOSP, FAIRFAX, VA USA
关键词
ovarian mucinous tumors; appendiceal mucinous lesions; pseudomyxoma peritonei; microdissection; loss of heterozygosity;
D O I
10.1016/S0046-8177(96)90370-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The coexistence of mucinous ovarian and appendiceal tumors in association with pseudomyxoma peritonei (PP) is well established. However, it has not been determined whether they represent independent or metastatic neoplasms. The authors analyzed microsatellites on chromosome 17q 21.3-22 (nm23), 3p 25-26 (von Hippel Lindau disease [VHL] gene), and 5q 21-22 (D5S346 locus) in 12 synchronous ovarian and appendiceal mucinous lesions. Loss of heterozygosity (LOH) at the nm23 locus has been shown previously in ovarian carcinomas, and genetic alterations at both the 3p and 5q loci have been reported in colorectal carcinomas. The ovarian lesions consisted of nine mucinous tumors of low malignant potential and three invasive adenocarcinomas, and the appendiceal leisons consisted of eight carcinomas without invasion, two invasive carcinomas, and two mucosal hyperplasias. DNA was extracted from microdissected cells obtained from formalin-fixed, paraffin-embedded tissue sections and amplified by polymerase chain reaction. In three specimens, genetic alterations occurred at 17q 21.3-22 in only the ovarian tumors. One of these cases showed LOH on chromosome 5q 21-22 in only the appendiceal tumor. In three other specimens, LOH at the same locus was found in both tumors. Six specimens did not show LOH at any locus. These results suggest that a subset of synchronous mucinos ovarian and appendiceal lesions showing different LOH patterns in both sites most likely represent patients with two separate primary lesions. Another group of specimens with the same allelic loss in both tumors most likely represent patients with a single primary and metastatic spread. Thus, genetic analysis of these lesions may be useful in investigating the origin of histologically similar synchronous tumors. This is a US government work. There are no restrictions on its use.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 33 条
[1]  
[Anonymous], 1952, SPREAD TUMORS HUMAN
[2]   SOMATIC ALLELIC LOSS AT THE DCC, APC, NM23-H1 AND P53 TUMOR-SUPPRESSOR GENE LOCI IN HUMAN PROSTATIC-CARCINOMA [J].
BREWSTER, SF ;
BROWNE, S ;
BROWN, KW .
JOURNAL OF UROLOGY, 1994, 151 (04) :1073-1077
[3]  
BYRON RL, 1966, SURG GYNECOL OBSTETR, V122, P509
[4]  
CAMPBELL JS, 1973, OBSTET GYNECOL, V42, P897
[5]  
CARLETON CC, 1955, ARCH PATHOL, V60, P39
[6]  
ECCLES DM, 1990, ONCOGENE, V5, P1599
[7]   PSEUDOMYXOMA PERITONEI [J].
GHOSH, BC ;
HUVOS, AG ;
WHITELEY, HW .
DISEASES OF THE COLON & RECTUM, 1972, 15 (06) :420-425
[8]   MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA [J].
GNARRA, JR ;
TORY, K ;
WENG, Y ;
SCHMIDT, L ;
WEI, MH ;
LI, H ;
LATIF, F ;
LIU, S ;
CHEN, F ;
DUH, FM ;
LUBENSKY, I ;
DUAN, DR ;
FLORENCE, C ;
POZZATTI, R ;
WALTHER, MM ;
BANDER, NH ;
GROSSMAN, HB ;
BRAUCH, H ;
POMER, S ;
BROOKS, JD ;
ISAACS, WB ;
LERMAN, MI ;
ZBAR, B ;
LINEHAN, WM .
NATURE GENETICS, 1994, 7 (01) :85-90
[9]  
HALL JM, 1992, AM J HUM GENET, V50, P1235
[10]  
HIGA E, 1973, CANCER-AM CANCER SOC, V32, P1525, DOI 10.1002/1097-0142(197312)32:6<1525::AID-CNCR2820320632>3.0.CO